Cargando…

Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy

Glycoprotein E (gE) is one of the most abundant glycoproteins in varicella-zoster virus and plays pivotal roles in virus replication and transmission between ganglia cells. Its extracellular domain has been successfully used as an antigen in subunit zoster vaccines. The intracellular C-terminal doma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Han, Wang, Yunfei, Luan, Ning, Lin, Kangyang, Liu, Cunbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704662/ https://www.ncbi.nlm.nih.gov/pubmed/34960186 http://dx.doi.org/10.3390/vaccines9121440

Ejemplares similares

Evaluation of the Immunological Efficacy of an LNP-mRNA Vaccine Prepared from Varicella Zoster Virus Glycoprotein gE with a Double-Mutated Carboxyl Terminus in Different Untranslated Regions in Mice
por: Wang, Yunfei, et al.
Publicado: (2023)

LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice
por: Luan, Ning, et al.
Publicado: (2022)

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine
por: Luan, Ning, et al.
Publicado: (2022)

Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice
por: Cao, Han, et al.
Publicado: (2021)

Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods
por: Lin, Kangyang, et al.
Publicado: (2023)

Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice
por: Luan, Ning, et al.
Publicado: (2023)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

Processing of virus-specific glycoproteins of varicella zoster virus
por: Namazue, Junko, et al.
Publicado: (1985)

An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
por: Cao, Han, et al.
Publicado: (2021)

Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro
por: Luan, Ning, et al.
Publicado: (2022)

Varicella zoster virus reactivation and mRNA vaccines as a trigger
por: Lladó, Iñigo, et al.
Publicado: (2021)

Development of an Indirect ELISA Kit for Rapid Detection of Varicella-Zoster Virus Antibody by Glycoprotein E
por: Niu, Yan, et al.
Publicado: (2022)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration
por: González-Motos, Víctor, et al.
Publicado: (2017)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
por: Gelman, Daniel, et al.
Publicado: (2023)

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice
por: Xue, Wenhui, et al.
Publicado: (2022)

Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice
por: Liu, Jie, et al.
Publicado: (2022)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Varicella-Zoster Meningitis With Hypoglycorrhachia in an Immunocompetent Patient Presenting With Disseminated Varicella-Zoster Infection
por: Sohal, Raman J, et al.
Publicado: (2020)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation
por: Sadaoka, Tomohiko, et al.
Publicado: (2022)

Culture media optimization for Chinese hamster ovary cell growth and expression of recombinant varicella-zoster virus glycoprotein E
por: Kim, Kwang Sung, et al.
Publicado: (2021)

Lineages of varicella-zoster virus
por: McGeoch, Duncan J.
Publicado: (2009)

Etymologia: Varicella Zoster Virus
Publicado: (2015)

Varicella-zoster virus myeloencephalitis()
por: Matsuo, Takahiro, et al.
Publicado: (2017)

Varicella Zoster Virus Encephalitis
por: Lizzi, Jared, et al.
Publicado: (2019)

Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020)

The Cytoplasmic Domain of Varicella-Zoster Virus Glycoprotein H Regulates Syncytia Formation and Skin Pathogenesis
por: Yang, Edward, et al.
Publicado: (2014)

Varicella-zoster virus glycoprotein expression differentially induces the unfolded protein response in infected cells
por: Carpenter, John E., et al.
Publicado: (2014)

The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion
por: Oliver, Stefan L., et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association
por: Di Pauli, Franziska, et al.
Publicado: (2021)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Simian Varicella Virus Pathogenesis in Skin during Varicella and Zoster
por: Mahalingam, Ravi, et al.
Publicado: (2022)

Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus
por: Li, Junli, et al.
Publicado: (2022)

Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation
por: Sato, Tetsuko, et al.
Publicado: (2021)

Imposter Zoster: An Atypical Case of Varicella-Zoster Virus Infection
por: Dhaliwal, Galvin, et al.
Publicado: (2023)

New Variant of Varicella-Zoster Virus
por: Tipples, Graham A., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_7o6j44i746arsj5vmogci1r8ie